Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | -9.52% | -15.87% | -83.73% |
May. 24 | Top Midday Decliners | MT |
May. 24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Financials (USD)
Sales 2024 * | 6K | Sales 2025 * | - | Capitalization | 77.66M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -35M | EV / Sales 2024 * | 12,944 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.38
x | P/E ratio 2025 * |
-2.01
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.44% |
1 day | -9.52% | ||
1 week | -15.87% | ||
Current month | -15.87% | ||
1 month | -43.28% | ||
3 months | -64.15% | ||
6 months | -82.24% | ||
Current year | -83.73% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Lourie Zak
DFI | Director of Finance/CFO | 61 | 23-08-27 |
Paul Scigalla
CTO | Chief Tech/Sci/R&D Officer | 79 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tyree
BRD | Director/Board Member | 71 | 12-05-01 |
John Thomas
BRD | Director/Board Member | 66 | 02-08-31 |
John Smither
BRD | Director/Board Member | 71 | 23-09-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.28 | -9.52% | 178,814 |
24-06-06 | 2.52 | -2.70% | 142,059 |
24-06-05 | 2.59 | +0.78% | 148,382 |
24-06-04 | 2.57 | -8.54% | 238,413 |
24-06-03 | 2.81 | +3.69% | 334,472 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.73% | 77.66M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+2.15% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- GNLX Stock